{
  "created_at": "Fri Jul 15 3:28:0 +0000 2022",
  "id_str": "1547749266226941952",
  "full_text": "AstraZeneca-Oxford and Pfizer-BioNTech ramped up production early, and by the end of the study period had by far the most doses administered outside China https://t.co/7jSQkX5VGa",
  "display_text_range": [
    0,
    178
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/7jSQkX5VGa",
        "expanded_url": "https://econ.st/3RAMMbV",
        "display_url": "econ.st/3RAMMbV",
        "indices": [
          155,
          178
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 32,
  "favorite_count": 98,
  "possibly_sensitive": false,
  "original_created_at": "Fri Jul 15 01:05:55 +0000 2022"
}